MedTrace Logo

Study to Understand Gaining Access to Blood Glucose Records

NCT02956642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2025-04-30

Study results available
· View outcomes & findings →

Summary

This study is a two-arm randomized controlled trial in which participants will receive either the Livongo Health system or iHealth glucose meter for measuring their blood glucose. The study hypothesizes the use of the Livongo Health system results in a greater improvement in A1c compared to standard blood glucose monitoring, as demonstrated by the iHealth Bluetooth-enabled glucose meter.

Conditions

Interventions

DEVICE

Livongo Health System

Participants will be asked to use the Livongo Health System to manage their blood glucose.

DEVICE

iHealth Glucose Meter

Participants will be asked to use the iHealth Glucose Meter to take blood glucose measurements.

Sponsors & Collaborators

Principal Investigators

  • Jenise Wong, MD, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-14
Primary Completion
2021-01-17
Completion
2021-01-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02956642 on ClinicalTrials.gov